Delivery Order SPE2DB20D1004-SPE2DB25FNKSF
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,633.36 to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5-gram packages. This contract was competitively awarded with no set-aside designation and employs firm fixed pricing. The delivery order was issued on August 25, 2025, with an ultimate completion date of August 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,605.63 to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5 gram packages on August 22, 2025, with completion expected by August 25, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a competitively awarded transaction under AmerisourceBergen's existing contract vehicle. The pharmaceutical product will be delivered to the company's facility in Conshohocken,...
- The Defense Logistics Agency awarded a $2,135.95 delivery order to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5-gram packaging, with an ultimate completion date of August 29, 2025. This is a firm fixed price contract with no set-aside designation, issued competitively to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's broader federal contracting...
- The Defense Logistics Agency awarded a $1,398.21 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for Testosterone 1% (25mg/2.5g) in 2.5-gram packages, with an ultimate completion date of September 10, 2025. This non-set-aside competitive award is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages, with a ceiling value of $1,976.82. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The work is scheduled for completion by August 22, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $1,296.00 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages, with a completion date of September 10, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a child contract, indicating it falls under a larger indefinite delivery vehicle. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages, with a contract value of $1,645.21 and a completion date of August 13, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $1,200.33 to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5-gram packets. The contract is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and was competitively awarded without a set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,938.18 to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5-gram packages on September 10, 2025, with completion expected by September 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,466.98 on September 3, 2025, for the supply of Testosterone 1% (50 mg/5 g) in unit dose packages of 5 grams. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by September 4, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a continuation of the company's ongoing...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB25FNKSFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,428.90 to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5-gram packages on September 11, 2025, with completion scheduled for September 12, 2025. This firm fixed-price delivery order, which was competitively awarded without set-aside restrictions, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement fulfilling military healthcare supply needs through the federal medical procurement system. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen maintains an extensive portfolio of drug supply contracts with the Defense Logistics Agency and serves military healthcare systems, the Defense Health Agency, U.S. Coast Guard, and other government entities. The company's federal contracting demonstrates consistent capability in meeting diverse pharmaceutical procurement requirements across multiple therapeutic domains through competitive delivery order awards.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 9/11/25 |